Medindia

X

HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records

Wednesday, June 11, 2008 General News J E 4
Advertisement
BOTHELL, Wash., June 11 Cardiac Science(Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation,rehabilitation, and informatics products, announced today that it completedcertification for its HeartCentrix(R) ECG informatics software with theAllscripts Electronic Health Record (EHR).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

"Allscripts is a major player in electronic health systems, with more than40,000 physician clients in some 5,000 health organizations ranging from solodoctors' offices to acute care hospitals. Physicians using Allscripts can nowconnect to Burdick(R) and Quinton(R) brand ECG devices, cardiac stresssystems, Holter devices, and more," said Tony Titus, vice president ofmarketing, Cardiac Science. "By allowing diagnostic data from our products toflow seamlessly to the Allscripts EHR, this partnership makes both ourcompanies' product offerings more attractive to the markets we serve."

The connectivity between Cardiac Science's equipment and the AllscriptsEHR will help physicians streamline the diagnostic cardiology workflow intheir offices, eliminate a source of data transcription errors, and provide aunified view of patient diagnostic data. With HeartCentrix ECG informatics,physicians will have immediate access to view or edit a patient's test resultselectronically and later retrieve the data from the Electronic Health Record.

Cardiac Science connects to Allscripts via the company's UniversalApplication Integrator (UAI), an innovative application that enables certifieddevice vendors to quickly and easily connect to Allscripts Electronic HealthRecords.

"This is a big win for Allscripts and Cardiac Science, as well as for ourcustomers," said Steven Tolle, Vice President of Product Management forAllscripts Clinical Solutions Group. "With HeartCentrix achieving UAIcertification, clinicians using Cardiac Science equipment can now improvepatient care and safety by integrating their devices with our ElectronicHealth Record."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanceddiagnostic and therapeutic cardiology devices and systems, including automatedexternal defibrillators (AEDs), electrocardiograph devices (ECGs), cardiacstress systems and treadmills, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, and cardiology datamanagement systems (informatics) that connect with hospital information (HIS),electronic medical record (EMR), and other information systems. The Companysells a variety of related products and consumables, and provides a portfolioof training, maintenance, and support services. Cardiac Science, the successorto the cardiac businesses that established the trusted Burdick(R),HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered inBothell, Washington. With customers in more than 100 countries worldwide, thecompany has operations in North America, Europe, and Asia. For information,call 425.402.2000 or visit http://www.cardiacscience.com .

Forward-Looking Statements

This press release contains forward-looking statements including, but notlimited to, those that infer that Cardiac Science Corporation's future revenueand profits may increase as a result of the connectivity of its products withAllscripts' products. These statements and their underlying assumptionsinvolve a number of risks and uncertainties and are not guarantees of futureperformance. These are forward-looking statements for purposes of the safeharbor provisions under the Private Securities Litigation Reform Act of 1995.The words "believe," "expect," "intend," "anticipate," variations of suchwords, and similar expressions identify forward-looking statements, but theirabsence does not mean that the statement is not forward looking. Actualresults may vary significan
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
CuraGen Announces Expansion of CR011-vcMMAE Phase ...
S
ev3 Inc. to Present at the Jefferies 2nd Annual He...